| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/25/2011 | US8043604 Ultrasonography using time- and temperature-sensitive variable adhesion coupling gels |
| 10/25/2011 | CA2655596C Multiparticulate osmotic delivery system |
| 10/25/2011 | CA2580910C Pharmaceutical composition comprising temozolomide ester |
| 10/25/2011 | CA2537797C Buccal drug delivery |
| 10/25/2011 | CA2536487C Rapid dissolution formulation of a calcium receptor-active compound |
| 10/25/2011 | CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 10/25/2011 | CA2454658C Methods for treating joint inflammation, pain, and loss of mobility |
| 10/25/2011 | CA2341568C Stabilized pharmaceutical composition in lyophilized form |
| 10/20/2011 | WO2011130753A2 Functionalized nano- and micro-materials for medical therapies |
| 10/20/2011 | WO2011130716A2 A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers |
| 10/20/2011 | WO2011130674A1 Prodrug compositions, prodrug nanoparticles, and methods of use thereof |
| 10/20/2011 | WO2011130487A1 Probiotic confection and lipid compositions |
| 10/20/2011 | WO2011130486A2 Combination treatments and formulations for cancer |
| 10/20/2011 | WO2011130462A2 Intraocular pressure reduction with intracameral bimatoprost implants |
| 10/20/2011 | WO2011130440A1 Effervescent tablets comprising an oil component |
| 10/20/2011 | WO2011130379A1 Benzonapthyridine compositions and uses thereof |
| 10/20/2011 | WO2011130362A2 Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings |
| 10/20/2011 | WO2011130246A2 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
| 10/20/2011 | WO2011130114A1 Nanoparticles and nanoparticle compositions |
| 10/20/2011 | WO2011130112A1 Medical devices with galvanic particulates |
| 10/20/2011 | WO2011129812A1 Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same |
| 10/20/2011 | WO2011129792A1 Water dispersible formulations comprising cefpodoxime proxetil |
| 10/20/2011 | WO2011129627A2 Docetaxel-loaded thermosensitive liquid suppository composition for rectal administration |
| 10/20/2011 | WO2011129588A2 Polymer/liposome nanocomposite composition for percutaneous absorption, and method for preparing same |
| 10/20/2011 | WO2011129579A2 Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent |
| 10/20/2011 | WO2011129549A2 Anticancer drug delivery system using ph-sensitive metal nanoparticles |
| 10/20/2011 | WO2011129461A1 Method and ophthalmic composition for treating retinal disease |
| 10/20/2011 | WO2011129269A1 Adhesive composition for medical use, adhesive patch for medical use, and method for producing the composition |
| 10/20/2011 | WO2011128910A2 A drug delivery solid dosage formulation of sirolimus |
| 10/20/2011 | WO2011128906A1 Ciprofloxacin dry syrup composition |
| 10/20/2011 | WO2011128896A1 Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders |
| 10/20/2011 | WO2011128783A2 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof |
| 10/20/2011 | WO2011128642A1 Compoisitons comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists |
| 10/20/2011 | WO2011128635A2 Anti-abuse pharmaceutical compositions |
| 10/20/2011 | WO2011128634A2 Over the counter pharmaceutical compositions |
| 10/20/2011 | WO2011128633A2 Oral pharmaceutical dispersion compositions |
| 10/20/2011 | WO2011128632A2 Gelled pharmaceutical composition |
| 10/20/2011 | WO2011128631A2 Vegetarian oral pharmaceutical and nutraceutical compositions |
| 10/20/2011 | WO2011128630A2 Anti-abuse gelled pharmaceutical compositions |
| 10/20/2011 | WO2011128629A2 Lipid-vectored drug compositions |
| 10/20/2011 | WO2011128628A2 Gelled oral pharmaceutical compositions |
| 10/20/2011 | WO2011128627A2 Oral veterinary pharmaceutical and nutraceutical compositions |
| 10/20/2011 | WO2011128626A1 Essential fatty acid gelled composition |
| 10/20/2011 | WO2011128625A2 Divisible oral pharmaceutical compositions |
| 10/20/2011 | WO2011128623A2 Improvements relating to antiviral compositions |
| 10/20/2011 | WO2011128424A1 Methods and compositions for improving implant osseointegration |
| 10/20/2011 | WO2011128364A1 Acetaminophen composition |
| 10/20/2011 | WO2011128337A2 Low-dosed solid oral dosage forms for hrt |
| 10/20/2011 | WO2011128336A1 Very low-dosed solid oral dosage forms for hrt |
| 10/20/2011 | WO2011128245A1 Homeopathic medicament comprising phenacetin for the treatment of cancer |
| 10/20/2011 | WO2011128230A1 Effervescent pharmaceutical compositions containing n-acetylcysteine |
| 10/20/2011 | WO2011127994A1 Active substance complex and formulation comprising it |
| 10/20/2011 | WO2011127829A1 Use of carbon nanoparticles as externl applied medicament for treating hemorrhoid |
| 10/20/2011 | WO2011127629A1 Pharmaceutical product of diphosphonate injection and preparation method thereof |
| 10/20/2011 | WO2011127532A1 Tethered matrix metalloproteinase inhibitor |
| 10/20/2011 | WO2011101866A3 Gastric retention formulation containing baclofen |
| 10/20/2011 | WO2011098578A3 Liposome system for ocular administration |
| 10/20/2011 | WO2011093815A3 Pharmaceutical compositions comprising formoterol and mometasone |
| 10/20/2011 | WO2011089595A3 Sustained-release nucleic acid matrix compositions |
| 10/20/2011 | WO2011087705A3 Fine particle croscarmellose and uses thereof |
| 10/20/2011 | WO2011082368A3 Polymeric conjugates of aromatic amine containing compounds including releasable urea linker |
| 10/20/2011 | WO2011070318A3 Topical formulation |
| 10/20/2011 | WO2011069076A3 Sustained release donepezil formulations |
| 10/20/2011 | WO2011068963A3 Integrated ingestible event marker system with pharmaceutical product |
| 10/20/2011 | WO2011066980A3 Oral dosage forms with reduced potential for drug abuse |
| 10/20/2011 | WO2011063394A3 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 10/20/2011 | WO2011059198A3 Pharmaceutical composition containing a bisphosphonate |
| 10/20/2011 | WO2011056978A3 S isomers of alpha-methyl hydrocinnamic acid for the treatment of blood disorders |
| 10/20/2011 | WO2011049327A3 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 10/20/2011 | WO2011047173A9 Pharmaceutical compositions for oral administration |
| 10/20/2011 | WO2011039259A3 Mucoadhesive polymers having vitamin b partial structures |
| 10/20/2011 | WO2011036357A3 Stable, liquid, ready-to-use ketoprofen formulation |
| 10/20/2011 | WO2011006504A3 Treatment of hyperproliferative conditions |
| 10/20/2011 | WO2010130393A3 Orodispersible tablet containing a vardenafil salt |
| 10/20/2011 | US20110257726 Scaffolds for organ reconstruction and augmentation |
| 10/20/2011 | US20110257628 Instrument for alleviating addictive drug craving, method for using same and method for treating addictive drug dependence |
| 10/20/2011 | US20110257623 Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same |
| 10/20/2011 | US20110257586 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy |
| 10/20/2011 | US20110257239 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 10/20/2011 | US20110257141 Transdermal pharmaceutical formulation for minimizing skin residues |
| 10/20/2011 | US20110257132 Charged phospholipid compositions and methods for their use |
| 10/20/2011 | US20110256305 Turbine Coating Apparatus And Spray Gun Assembly Therefor |
| 10/20/2011 | US20110256235 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 10/20/2011 | US20110256231 Method for preparing a micro-particle drug in hemisphere-shaped dosage form and applications thereof |
| 10/20/2011 | US20110256230 Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting |
| 10/20/2011 | US20110256229 Rapid-acting pharmaceutical composition |
| 10/20/2011 | US20110256228 Solid Forms for Tissue Repair Background of the Invention |
| 10/20/2011 | US20110256227 Controlled polyplex assembly |
| 10/20/2011 | US20110256226 Opioid agonist formulations with releasable and sequestered antagonist |
| 10/20/2011 | US20110256225 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same |
| 10/20/2011 | US20110256224 Methods and compositions for targeted delivery |
| 10/20/2011 | US20110256223 Gastric retained gabapentin dosage form |
| 10/20/2011 | US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site |
| 10/20/2011 | US20110256221 Pharmaceutical formulations of olmesartan |
| 10/20/2011 | US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof |
| 10/20/2011 | US20110256219 Manufacturing Solid Pharmaceutical Dosage Forms With Visible Micro- And Nanostructured Surfaces And Micro- And Nanostructured Pharmaceutical Dosage Form |
| 10/20/2011 | US20110256218 Controlled release compositions comprising meclizine or related piperazine derivatives |
| 10/20/2011 | US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 10/20/2011 | US20110256216 Probiotic Confection and Lipid Compositions |
| 10/20/2011 | US20110256215 Non-pegylated liposomal doxorubicin triple combination therapy |